Wojta J - Search Results

1

Sandwich ELISA for t-PA antigen employing a monoclonal antibody.

Korninger C, Speiser W, Wojta J, Binder BR. Korninger C, et al. Among authors: wojta j. Thromb Res. 1986 Feb 15;41(4):527-35. doi: 10.1016/0049-3848(86)91698-1. Thromb Res. 1986. PMID: 3083527

2

Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantation.

Katsaros KM, Kastl SP, Huber K, Zorn G, Maurer G, Glogar D, Wojta J, Christ G, Speidl WS. Katsaros KM, et al. Among authors: wojta j. Thromb Res. 2008;123(1):79-84. doi: 10.1016/j.thromres.2008.04.017. Epub 2008 Jun 16. Thromb Res. 2008. PMID: 18558425

3

Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction.

Speidl WS, Nikfardjam M, Niessner A, Zeiner A, Jordanova N, Zorn G, Maurer G, Schreiber W, Wojta J, Huber K. Speidl WS, et al. Among authors: wojta j. Thromb Res. 2007;119(3):331-6. doi: 10.1016/j.thromres.2006.02.011. Epub 2006 Apr 17. Thromb Res. 2007. PMID: 16616324 Clinical Trial.

4

Circulating t-PA antigen predicts major adverse coronary events in patients with stable coronary artery disease--a 13-year follow-up.

Niessner A, Graf S, Nikfardjam M, Speidl WS, Huber-Beckmann R, Zorn G, Wojta J, Huber K. Niessner A, et al. Among authors: wojta j. Thromb Haemost. 2003 Aug;90(2):344-50. doi: 10.1160/TH02-10-0185. Thromb Haemost. 2003. PMID: 12888883

5

Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary prourokinase.

Wojta J, Kirchheimer JC, Turcu L, Christ G, Binder BR. Wojta J, et al. Thromb Haemost. 1986 Jun 30;55(3):347-51. Thromb Haemost. 1986. PMID: 3092391

6

Endogenous t-PA-antigen is an independent predictor of adverse cardiovascular events and all-cause death in patients with atrial fibrillation.

Freynhofer MK, Draxler DF, Gruber SC, Bruno V, Höchtl T, Fellner B, Jakl-Kotauschek G, Wojta J, Pabinger-Fasching I, Huber K, Ay C. Freynhofer MK, et al. Among authors: wojta j. J Thromb Haemost. 2013 Jun;11(6):1069-77. doi: 10.1111/jth.12213. J Thromb Haemost. 2013. PMID: 23557188

7

PAI-I 4G/5G polymorphism and sudden cardiac death in patients with coronary artery disease.

Anvari A, Schuster E, Gottsauner-Wolf M, Wojta J, Huber K. Anvari A, et al. Among authors: wojta j. Thromb Res. 2001 Jul 15;103(2):103-7. doi: 10.1016/s0049-3848(01)00277-8. Thromb Res. 2001. PMID: 11457467

8

Changes in the fibrinolytic system in patients with peripheral arterial occlusive disease undergoing percutaneous transluminal angioplasty.

Roller RE, Janisch S, Carroll V, Kvas E, Pilger E, Binder BR, Wojta J. Roller RE, et al. Among authors: wojta j. Thromb Res. 1999 May 15;94(4):241-7. doi: 10.1016/s0049-3848(99)00002-x. Thromb Res. 1999. PMID: 10336240

9

Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells.

Wojta J, Gallicchio M, Zoellner H, Hufnagl P, Last K, Filonzi EL, Binder BR, Hamilton JA, McGrath K. Wojta J, et al. Thromb Haemost. 1993 Sep 1;70(3):469-74. Thromb Haemost. 1993. PMID: 8259551

10

Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.

Wojta J, Turcu L, Wagner OF, Korninger C, Binder BR. Wojta J, et al. J Lab Clin Med. 1987 Jun;109(6):665-71. J Lab Clin Med. 1987. PMID: 3108431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results